Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 15 Jan 2025

Adding capivasertib to fulvestrant in patients with hormone receptor-positive advanced breast cancer: a cost-effectiveness analysis

in Drugs Outcomes Research and Policies

Yitian Lang
Qingqing Chai
Yan Lin
Bin Wu
Xiaoyan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1495082

239 views

Original Research

Published on 15 Jan 2025

The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review

in Drugs Outcomes Research and Policies

Yan Chen
Jiaojiao Zhao
Yifei Wang
Long Ge
Joey Sum-wing Kwong
Junjie Lan
Rui Zhang
Huaye Zhao
Linfang Hu
Jiaxue Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1530999

237 views

Original Research

Accepted on 14 Jan 2025

Drug utilization study of antiparkinsonian medication in Romania during 25 years

in Drugs Outcomes Research and Policies

Camelia Bucsa
Denisa Bruhs
Anamaria Apan
Elena Ovidia Francu
Cristina Mogosan
Irina Iaru

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1534344

Review

Published on 14 Jan 2025

Discussion on the optimization of personalized medication using information systems based on pharmacogenomics: an example using colorectal cancer

in Drugs Outcomes Research and Policies

Mengying Yuan
Yuankun Zheng
Fei Wang
Niuniu Bai
Haoling Zhang
Yuan Bian
Hao Liu
Xia He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1516469

146 views

Systematic Review

Accepted on 10 Jan 2025

Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and costeffectiveness

in Drugs Outcomes Research and Policies

Narcis Cardoner
Luis Gutiérrez-Rojas
Pilar A Saiz
Guillermo Lahera
Miguel Angel Alvarez-Mon
Pino Alonso Ortega
María Perez-Paramo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1483770

Original Research

Published on 10 Jan 2025

Survival analysis of a 16-year cohort of follicular lymphoma patients receiving systemic treatment in Brazil

in Drugs Outcomes Research and Policies

Pamela Santos Azevedo
Isabella Zuppo Laper
Deborah Marta do Santos Oliveira
Adriano de Paula Sabino
Marina Morgado Garcia
Isabela Cristina Menezes de Freitas
Wallace Mateus Prata
Mariângela Leal Cherchiglia
Juliana Álvares-Teodoro
Francisco de Assis Acurcio

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1414244

280 views

Systematic Review

Accepted on 09 Jan 2025

How Much Can We Save by Applying Artificial Intelligence in Evidence Synthesis? Results from a Pragmatic Review to Quantify Workload Efficiencies and Cost Savings

in Drugs Outcomes Research and Policies

Seye Abogunrin
Jeffrey M Muir
Clarissa Zerbini
Grammati Sarri

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1454245

Brief Research Report

Accepted on 09 Jan 2025

Consumers' Expected Information Search Behavior for a Pharmaceutical Treatment

in Drugs Outcomes Research and Policies

Yifei Liu
Jack E Fincham
Morgan L Sperry

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1466352

Original Research

Accepted on 09 Jan 2025

Challenging the Curve: Can ChatGPT-Generated MCQs Reduce Grade Inflation in Pharmacy Education

in Drugs Outcomes Research and Policies

Dalia Almaghaslah

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1516381

Systematic Review

Published on 08 Jan 2025

Efficacy and safety of anticoagulants on venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials

in Drugs Outcomes Research and Policies

Weijie Fu
Maolin Zhao
Sheng Ding
Mei Xin
Ke Yang
Li Jiang
Fan Wu
Xiaochen Wu
Jian Wang
Jie Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519869

223 views

Original Research

Accepted on 07 Jan 2025

Hemoglobin-to-Red Blood Cell Distribution Width Ratio as a Protective Factor Against Coronary Artery Disease: A Cross-Sectional Analysis of NHANES (2011-2018

in Drugs Outcomes Research and Policies

Xin-da Wang
Chaoya Li
Jia Hu
Fen Cao
Li Zhu
Yongzhi Zhu
Zhongzheng Wen
Jun Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1534479

Original Research

Published on 07 Jan 2025

Appropriateness and inappropriate medication predictors of stress ulcer prophylaxis in the intensive care unit

in Drugs Outcomes Research and Policies

Pan Zhang
Siyang Wang
Tingting Zhi
Naobei Ye
Haonan Sun
Xingyu Qin
Shuhan Xu
Ruiqin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401335

195 views

Original Research

Published on 07 Jan 2025

Doctor, what is my risk of bleeding after cardiac surgery while on combined anticoagulant with antiplatelet therapy? A validated nomogram for risk assessment

in Drugs Outcomes Research and Policies

Haolong Han
Hang Xu
Jifan Zhang
Weihui Zhang
Yi Yang
Xia Wang
Li Wang
Dongjin Wang
Weihong Ge

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1528390

109 views

Original Research

Published on 07 Jan 2025

Analysis of factors influencing the awareness of inpatients regarding hospital clinical pharmacy services and willingness to pay: a multicenter survey in Hebei Province, China

in Drugs Outcomes Research and Policies

Ruixia Yang
Xin Wang
Huizhen Wu
Qian Sun
Sijie Zhang
Qian Dong
Mengjiao Li
Xiaoli Xu
Jing Bai
Ping Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1520058

141 views

Original Research

Published on 07 Jan 2025

Analysis of drug pricing drivers under South Korea’s pharmaco-economic evaluation exemption policy (2015–2022)

in Drugs Outcomes Research and Policies

Seung Rae Yu
Jong Hyuk Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519491

117 views

Original Research

Published on 07 Jan 2025

Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in South Africa

in Drugs Outcomes Research and Policies

Rochelle Woudberg
Edina Sinanovic

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1511603

291 views

Navigation group

Articles

Adding capivasertib to fulvestrant in patients with hormone receptor-positive advanced breast cancer: a cost-effectiveness analysis

The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review

Drug utilization study of antiparkinsonian medication in Romania during 25 years

Discussion on the optimization of personalized medication using information systems based on pharmacogenomics: an example using colorectal cancer

Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and costeffectiveness

Survival analysis of a 16-year cohort of follicular lymphoma patients receiving systemic treatment in Brazil

How Much Can We Save by Applying Artificial Intelligence in Evidence Synthesis? Results from a Pragmatic Review to Quantify Workload Efficiencies and Cost Savings

Consumers' Expected Information Search Behavior for a Pharmaceutical Treatment

Challenging the Curve: Can ChatGPT-Generated MCQs Reduce Grade Inflation in Pharmacy Education

Efficacy and safety of anticoagulants on venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials

Hemoglobin-to-Red Blood Cell Distribution Width Ratio as a Protective Factor Against Coronary Artery Disease: A Cross-Sectional Analysis of NHANES (2011-2018

Appropriateness and inappropriate medication predictors of stress ulcer prophylaxis in the intensive care unit

Doctor, what is my risk of bleeding after cardiac surgery while on combined anticoagulant with antiplatelet therapy? A validated nomogram for risk assessment

Analysis of factors influencing the awareness of inpatients regarding hospital clinical pharmacy services and willingness to pay: a multicenter survey in Hebei Province, China

Analysis of drug pricing drivers under South Korea’s pharmaco-economic evaluation exemption policy (2015–2022)

Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in South Africa